Biogen

Biogen

2026 Med Honors Award · Top Pharmaceutical Innovators

Biogen

Cambridge, MA, USA

Institution Profile

Recognized for Excellence As a Med Honors Top Pharmaceutical Innovator, Biogen stands at the forefront of neuroscience research and drug development. Founded in 1978, Biogen has pioneered treatments for multiple sclerosis (MS), spinal muscular atrophy (SMA), and Alzheimer's disease. The company's MS portfolio includes disease-modifying therapies that have transformed patient outcomes. Biogen's breakthrough in Alzheimer's treatment with lecanemab (Leqembi) represents a significant advancement in addressing the cognitive decline associated with the disease. Additionally, Biogen's commitment to rare diseases is exemplified by its development of nusinersen (Spinraza) for SMA, offering hope to patients with this devastating condition. Beyond neurology, Biogen is expanding into biosimilars and exploring treatments for neuropsychiatric conditions. Through relentless research and development, Biogen continues to push the boundaries of medicine, offering new hope to patients with complex neurological conditions worldwide.

Reviewed by the Med Honors Editorial Team

Profile last updated: July 9, 2026

Med Honors Award

2026 TOP PHARMACEUTICAL INNOVATORS

Biogen

Biogen

Address

Cambridge, MA, USA

Request an Introduction

Tell us what you're looking for. Our team will connect you with the right institution for your needs.

By submitting, you authorize Med Honors to transmit your contact information and message to a qualified institution and service providers used to process this request.

Med Honors

Med Honors is an independent national directory and editorial recognition platform covering physicians, dentists, practices, and healthcare institutions across the United States.

Part of the Expert Honors Network

Expert Honors

Med Honors is an independent directory and editorial recognition platform. Nomination is free and does not influence selection. See our Terms and disclosures for additional information.